MYTHF yields 2.09% · PFE yields 6.13%● Live data
📍 MYTHF pulled ahead of the other in Year 1
Combined, MYTHF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MYTHF + PFE for your $10,000?
Mytilineos S.A. operates in metallurgy, sustainable engineering solution, renewables and storage development, and power and gas sectors in Greece, the European Union, and internationally. Its principal business areas include the production of electricity and natural gas; operation of industrial and renewable energy plants; trading of gas; production of alumina and aluminum, as well as bauxite and recycled aluminum; and production, processing, and trading of metals, which include aluminum alloys and derivative products. The company also engages in the development and contract of solar and energy storage projects; contract of specialized large-scale integrated turn-key projects; construction of infrastructure projects; and provision of photovoltaic construction, as well as environmental solutions for water, liquid, and solid waste. In addition, it provides energy solutions; and a range of project management, engineering, procurement, construction, and plant commissioning services. The company was formerly known as Mytilineos Holdings S.A. and changed its name to Mytilineos S.A. in July 2019. Mytilineos S.A. was founded in 1908 and is headquartered in Athens, Greece.
Full MYTHF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.